Lewis D Hansen

Medicare Asp 2025. The crosswalks are intended to help understand which drug products (identified by ndcs) are. This quarterly memo summarizes the results of oig's comparison analysis based on asp and amp data reported for the first quarter 2025.

Several factors, including but not limited to the setting in which the product is used and its volume in medicare part b are evaluated before a decision about national pricing. The crosswalks are intended to help understand which drug products (identified by ndcs) are.